Herceptin trastuzumab - 440 mg Multi-dose Vial with Diluent

Description (Brief)
(From insert) Herceptin is a HER2/neu receptor antagonist indicated for:
-the threatment of HER2 overexpressing breast cancer
-the treatment of HER2-overexpressing metastatic gastirc or gastroesophageal junction adenocarcinoma
Currently not on view
date made
ca 2013
product expiration date
Genentech, Inc.
place made
United States: California, South San Francisco
Physical Description
glass (overall material)
metal (overall material)
cardboard (overall material)
trastuzumab, 440mg (overall ingredient)
plastic (overall material)
overall: 3 1/4 in x 2 1/8 in x 1 1/2 in; 8.255 cm x 5.3975 cm x 3.81 cm
bottle of herceptin: 3 in x 1 5/8 in; 7.62 cm x 4.1275 cm
bottle of bacteriostatic water for injection: 2 3/4 in x 1 3/8 in; 6.985 cm x 3.4925 cm
overall: 4 1/2 in x 3 5/8 in x 2 3/4 in; 11.43 cm x 9.2075 cm x 6.985 cm
ID Number
catalog number
accession number
Credit Line
Gift of Genentech, Inc.
See more items in
Medicine and Science: Medicine
Health & Medicine
The Antibody Initiative
Antibody Initiative: Monoclonal Antibodies
Data Source
National Museum of American History